isoxazoles has been researched along with Cognition Disorders in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 20 (76.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, CM; Chapalamadugu, M; Gee, KW; Hogenkamp, D; Johnson, NH; Johnstone, T; London, SH; Titus, DJ | 1 |
| Atrakchi-Baranes, D; Biegon, A; Friedman Levi, Y; Kesner, E; Liraz-Zaltsman, S; Rosenblatt, K; Shohami, E; Silva, AJ; Slusher, B | 1 |
| Boehm, GW; Chumley, MJ; Eimerbrink, MJ; Hayes, HB; Hodges, SL; Pendry, RJ; Peterman, JL; White, JD; Wiles, JD | 1 |
| Alzarea, S; Rahman, S | 1 |
| Gen, K; Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Suzuki, H | 1 |
| Creus, M; Franch, J; Gutiérrez-Zotes, A; Labad, J; Lawrie, SM; Monseny, R; Montalvo, I; Ortega, L; Reynolds, RM; Vilella, E | 1 |
| Ciraulo, DA; Colaneri, L; Devine, E; Knapp, CM; Oscar-Berman, M; Putnam, M; Richambault, C; Richardson, MA; Sarid-Segal, O; Streeter, CC; Surprise, C; Waters, M | 1 |
| Blanco-Beregana, M; Budke, M; Fournier-Del Castillo, MC; Garcia-Fernandez, M; Garcia-Penas, JJ; Melero-Llorente, J; Perez-Jimenez, MÁ; Robles-Bermejo, F | 1 |
| Burdett, J; Duncan, JS; Hill, A; Koepp, MJ; Thompson, PJ; Townsend, L; Wandschneider, B | 1 |
| Deadwyler, SA; España, RA; Hampson, RE; Porrino, LJ; Rogers, GA | 1 |
| Beniak, TE; Birnbaum, AK; Leppik, IE; Marino, SE; Walczak, TS; White, JR | 1 |
| D'Souza, DC; Kane, JM; Keefe, RS; Patkar, AA; Tiller, JM; Yang, R; Youakim, JM | 1 |
| Citrome, L; Hochfeld, M; Meng, X | 1 |
| Arbon, EL; Boyle, J; Dijk, DJ; James, LM; Johnsen, S; Stanley, N; Wright, N | 1 |
| Arai, H; Iimura, Y; Nakajima, M; Sugano, H | 1 |
| Balabhadrapatruni, S; Darlington, CL; Masumura, C; Smith, PF; Zheng, Y | 1 |
| Gendle, DF; Grayson, B; Idris, NF; Lesage, AS; Mackie, C; McLean, SL; Neill, JC; Pemberton, DJ | 1 |
| Guerdjikova, AI; Keck, PE; Martens, B; McCoy, J; McElroy, SL; Moeller, D; Mori, N; Winstanley, E | 1 |
| Chen, G; Gong, M; Wang, HM; Xu, LH; Yan, M; Zhang, XM | 1 |
| Bae, KY; Chung, YC; Kim, JM; Kim, SW; Kim, SY; Lee, JH; Lee, YH; Shin, IS; Yoon, JS | 1 |
| Chen, C; Peng, M; Wang, CY; Wang, FF; Wang, YL | 1 |
| Kumar, A; Naidu, PS; Padi, SV; Seghal, N | 1 |
| Goldberg, TE; Weinberger, DR | 1 |
| Arneric, SP; Brioni, JD; Buckley, MJ; Decker, MW; Kim, DJ; O'Neill, AB | 1 |
| Bennani, YL; Black, LA; Decker, MW; Esbenshade, TA; Faghih, R; Fox, GB; Hancock, AA; Pan, JB | 1 |
| Eisenhauer, E; Maksymiuk, A; Maroun, JA; Pater, J; Stewart, DJ; Young, V | 1 |
1 review(s) available for isoxazoles and Cognition Disorders
| Article | Year |
|---|---|
The effects of clozapine on neurocognition: an overview.
Topics: Clozapine; Cognition; Cognition Disorders; Dopamine; Humans; Isoxazoles; Neuropsychological Tests; Piperidines; Receptors, Dopamine; Receptors, Muscarinic; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
7 trial(s) available for isoxazoles and Cognition Disorders
| Article | Year |
|---|---|
The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial.
Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Cognition Disorders; Drug Substitution; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Male; Memory, Short-Term; Neuropsychological Tests; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2014 |
Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
Topics: Adult; Aged; Alcohol Drinking; Alcohol-Related Disorders; Anticonvulsants; Cognition Disorders; Double-Blind Method; Female; Fructose; Humans; Isoxazoles; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Topiramate; Treatment Outcome; Young Adult; Zonisamide | 2015 |
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Benzhydryl Compounds; Benzodiazepines; Central Nervous System Stimulants; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Modafinil; Olanzapine; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Factor Analysis, Statistical; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Middle Aged; Mood Disorders; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome; Young Adult | 2011 |
Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep.
Topics: Adolescent; Adult; Allosteric Regulation; Arousal; Brain Waves; Cognition Disorders; Cross-Over Studies; Dose-Response Relationship, Drug; Electroencephalography; Humans; Isoxazoles; Male; Middle Aged; Nootropic Agents; Polysomnography; Psychomotor Performance; Receptors, AMPA; Sleep; Sleep Deprivation; Wakefulness | 2012 |
A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Middle Aged; Olanzapine; Regression Analysis; Schizophrenia; Treatment Outcome; Weight Gain; Young Adult; Zonisamide | 2012 |
Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Delayed-Action Preparations; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Monitoring; Female; Humans; Isoxazoles; Male; Middle Aged; Movement Disorders; Paliperidone Palmitate; Prevalence; Psychiatric Status Rating Scales; Pyrimidines; Republic of Korea; Risperidone; Schizophrenia; Young Adult | 2012 |
18 other study(ies) available for isoxazoles and Cognition Disorders
| Article | Year |
|---|---|
Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury.
Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Anilides; Animals; Atrophy; Brain; Brain Injuries, Traumatic; Chronic Disease; Cognition Disorders; Conditioning, Classical; Fear; Isoxazoles; Long-Term Potentiation; Male; Maze Learning; Memory, Short-Term; Rats, Sprague-Dawley; Synaptic Transmission | 2019 |
Enhancement of Brain d-Serine Mediates Recovery of Cognitive Function after Traumatic Brain Injury.
Topics: Animals; Brain Injuries, Traumatic; Cognition; Cognition Disorders; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Recovery of Function; Serine | 2018 |
The α5-GABA
Topics: Amyloid beta-Peptides; Animals; Body Weight; Brain-Derived Neurotrophic Factor; Cognition Disorders; Conditioning, Psychological; Fear; GABA Agonists; Gene Expression Regulation; Hippocampus; Isoxazoles; Lipopolysaccharides; Male; Membrane Glycoproteins; Memory; Mice; Mice, Inbred C57BL; Nuclear Receptor Subfamily 4, Group A, Member 2; Peptide Fragments; Protein-Tyrosine Kinases; RNA, Messenger; Triazines | 2019 |
Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antidepressive Agents; Anxiety; Anxiety Disorders; Astrocytes; Cognition; Cognition Disorders; Cognitive Dysfunction; Cytokines; Depression; Depressive Disorder, Major; Disease Models, Animal; Hippocampus; Inflammation; Isoxazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Phenylurea Compounds; Prefrontal Cortex | 2019 |
Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cognition; Cognition Disorders; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Young Adult | 2014 |
[Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis].
Topics: Acetamides; Anticonvulsants; Benzodiazepines; Child; Clobazam; Cognition Disorders; Dibenzazepines; Drug Substitution; Drug Therapy, Combination; Epilepsies, Partial; Frontal Lobe; Humans; Isoxazoles; Lacosamide; Language Disorders; Learning Disabilities; Male; Memory Disorders; Neuroimaging; Nitriles; Pyridones; Tuberous Sclerosis; Zonisamide | 2015 |
Effect of topiramate and zonisamide on fMRI cognitive networks.
Topics: Adult; Anticonvulsants; Brain; Cognition Disorders; Cross-Sectional Studies; Epilepsies, Partial; Female; Fructose; Functional Laterality; Humans; Image Processing, Computer-Assisted; Isoxazoles; Language; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Oxygen; Retrospective Studies; Topiramate; Zonisamide | 2017 |
Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717.
Topics: Animals; Brain Chemistry; Calcium; Cognition; Cognition Disorders; Electrophysiology; Glucose; Hippocampus; Image Processing, Computer-Assisted; Isoxazoles; Macaca mulatta; Male; Microscopy, Confocal; Neurons; Nootropic Agents; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Sleep Deprivation; Synapses | 2009 |
Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.
Topics: Adult; Anticonvulsants; Case-Control Studies; Cognition Disorders; Epilepsy; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Retrospective Studies; Risk Factors; Young Adult; Zonisamide | 2010 |
Stepwise synchronization through the corpus callosum is one cause of myoclonic jerks.
Topics: Anticonvulsants; Cognition Disorders; Corpus Callosum; Cortical Synchronization; Drug Resistance; Electroencephalography; Functional Laterality; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Myoclonus; Neurosurgical Procedures; Seizures; Syncope; Valproic Acid; Young Adult; Zonisamide | 2012 |
Effects of the putative cognitive-enhancing ampakine, CX717, on attention and object recognition memory.
Topics: Animals; Attention; Cognition; Cognition Disorders; Disease Models, Animal; Isoxazoles; Male; Memory; Memory Disorders; Neural Inhibition; Nootropic Agents; Rats; Rats, Wistar; Reaction Time; Recognition, Psychology; Time Factors; Treatment Outcome; Vestibular Diseases | 2011 |
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.
Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Attention; Behavior, Animal; Brain; Cognition Disorders; Discrimination Learning; Disease Models, Animal; Drug Interactions; Female; Half-Life; Hallucinogens; Isoxazoles; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Nicotinic Agonists; Phencyclidine; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Tissue Distribution | 2012 |
Parecoxib mitigates spatial memory impairment induced by sevoflurane anesthesia in aged rats.
Topics: Aging; Anesthetics, Intravenous; Animals; Blotting, Western; Cognition Disorders; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Hippocampus; Isoxazoles; Male; Maze Learning; Memory; Memory Disorders; Methyl Ethers; Microscopy, Electron, Transmission; Rats; Rats, Sprague-Dawley; Sevoflurane; Synapses | 2012 |
The cyclooxygenase-2 inhibitor parecoxib inhibits surgery-induced proinflammatory cytokine expression in the hippocampus in aged rats.
Topics: Aging; Animals; Cognition Disorders; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Encephalitis; Gene Expression; Hippocampus; Interleukin-1beta; Isoxazoles; Male; Postoperative Complications; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2012 |
Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cognition Disorders; Colchicine; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Injections, Intraventricular; Isoxazoles; Lipid Peroxidation; Male; Maze Learning; Memory; Naproxen; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Space Perception; Spatial Behavior; Sulfonamides; Time Factors | 2006 |
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Cognition Disorders; Diazepam; Isoxazoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1994 |
Effects of histamine H(3) receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup.
Topics: Animals; Anti-Anxiety Agents; Arousal; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Histamine Antagonists; Imidazoles; Impulsive Behavior; Isoxazoles; Ligands; Male; Methylphenidate; Motor Activity; Nicotinic Agonists; Psychomotor Performance; Pyrrolidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Histamine H3 | 2002 |
Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Canada; Carcinoma, Non-Small-Cell Lung; Cognition Disorders; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Lung Neoplasms; Male; Middle Aged; Oxazoles | 1986 |